Tsimihodimos V - Search Results

1

Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinic.

Liamis G, Tsimihodimos V, Doumas M, Spyrou A, Bairaktari E, Elisaf M. Liamis G, et al. Among authors: tsimihodimos v. Nephrol Dial Transplant. 2008 Jan;23(1):136-43. doi: 10.1093/ndt/gfm376. Epub 2007 Oct 11. Nephrol Dial Transplant. 2008. PMID: 17932111

2

The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic.

Tsimihodimos V, Bairaktari E, Tzallas C, Miltiadus G, Liberopoulos E, Elisaf M. Tsimihodimos V, et al. Thyroid. 1999 Apr;9(4):365-8. doi: 10.1089/thy.1999.9.365. Thyroid. 1999. PMID: 10319942

3

Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia.

Bairaktari ET, Tzallas CS, Tsimihodimos VK, Liberopoulos EN, Miltiadous GA, Elisaf MS. Bairaktari ET, et al. Among authors: tsimihodimos vk. J Cardiovasc Risk. 1999 Apr;6(2):113-6. doi: 10.1177/204748739900600208. J Cardiovasc Risk. 1999. PMID: 10353071 Clinical Trial.

4

Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patients.

Bairaktari E, Elisaf M, Katsaraki A, Tsimihodimos V, Tselepis AD, Siamopoulos KC, Tsolas O. Bairaktari E, et al. Among authors: tsimihodimos v. Clin Biochem. 1999 Jul;32(5):339-46. doi: 10.1016/s0009-9120(99)00031-4. Clin Biochem. 1999. PMID: 10480448

5

Hypouricemia in a patient with thyrotoxicosis.

Tsimihodimos V, Kalaitzides R, Elisaf M. Tsimihodimos V, et al. Eur J Endocrinol. 2001 Jan;144(1):83. doi: 10.1530/eje.0.1440083. Eur J Endocrinol. 2001. PMID: 11174842 No abstract available.

6

Fibrate treatment can increase serum creatinine levels.

Tsimihodimos V, Kakafika A, Elisaf M. Tsimihodimos V, et al. Nephrol Dial Transplant. 2001 Jun;16(6):1301. doi: 10.1093/ndt/16.6.1301. Nephrol Dial Transplant. 2001. PMID: 11390746 No abstract available.

7

Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemia.

Miltiadous G, Tsimihodimos V, Bairaktari E, Elisaf M. Miltiadous G, et al. Among authors: tsimihodimos v. Atherosclerosis. 2001 Jul;157(1):255-6. doi: 10.1016/s0021-9150(01)00536-6. Atherosclerosis. 2001. PMID: 11463004 No abstract available.

8

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD. Tsimihodimos V, et al. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):306-11. doi: 10.1161/hq0202.102918. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834533 Clinical Trial.

9

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Tsimihodimos V, et al. J Lipid Res. 2002 Feb;43(2):256-63. J Lipid Res. 2002. PMID: 11861667 Free article.

10

Fibrate-induced increase in serum urea and creatinine levels.

Tsimihodimos V, Bairaktari E, Elisaf M. Tsimihodimos V, et al. Nephrol Dial Transplant. 2002 Apr;17(4):682; author reply 682. doi: 10.1093/ndt/17.4.682. Nephrol Dial Transplant. 2002. PMID: 11917069 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters